Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer

Cancer Cell

Volumn 8, Issue 2, 2005, Pages 155-167

  Lee, Sungwoo ^a   Nakamura, Eijiro ^a   Yang, Haifeng ^a   Wei, Wenyi ^a   Linggi, Michelle S ^b   Sajan, Mini P ^c   Farese, Robert V ^c   Freeman, Robert S ^d   Carter, Bruce D ^b   Kaelin Jr , William G ^a,e   Schlisio, Susanne ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN C JUN; PROTEIN RET; SUCCINATE DEHYDROGENASE; SUCCINIC ACID; VON HIPPEL LINDAU PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEEDBACK SYSTEM; GENE MUTATION; HUMAN; HUMAN CELL; NERVE CELL; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN FAMILY; RAT;

EID: 23644436667     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.06.015     Document Type: Article

References (78)

1. R.J. Appelhoff, Y.M. Tian, R.R. Raval, H. Turley, A.L. Harris, C.W. Pugh, P.J. Ratcliffe, and J.M. Gleadle Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor J. Biol. Chem. 279 2004 38458 38465
2. O. Aprelikova, G.V. Chandramouli, M. Wood, J.R. Vasselli, J. Riss, J.K. Maranchie, W.M. Linehan, and J.C. Barrett Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors J. Cell. Biochem. 92 2004 491 501
3. L. Aravind, and E.V. Koonin The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases Genome Biol. 2 2001 RESEARCH0007
4. E. Berra, E. Benizri, A. Ginouves, V. Volmat, D. Roux, and J. Pouyssegur HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia EMBO J. 22 2003 4082 4090
5. R. Bruick, and S. McKnight A conserved family of prolyl-4-hydroxylases that modify HIF Science 294 2001 1337 1340
6. J. Bryant, J. Farmer, L.J. Kessler, R.R. Townsend, and K.L. Nathanson Pheochromocytoma: the expanding genetic differential diagnosis J. Natl. Cancer Inst. 95 2003 1196 1204
7. M. Cervellera, G. Raschella, G. Santilli, B. Tanno, A. Ventura, C. Mancini, C. Sevignani, B. Calabretta, and A. Sala Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB J. Biol. Chem. 275 2000 21055 21060
8. C.L. Cioffi, X.Q. Liu, P.A. Kosinski, M. Garay, and B.R. Bowen Differential regulation of HIF-1α prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells Biochem. Biophys. Res. Commun. 303 2003 947 953
9. S. Clifford, M. Cockman, A. Smallwood, D. Mole, E. Woodward, P. Maxwell, P. Ratcliffe, and E. Maher Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease Hum. Mol. Genet. 10 2001 1029 1038
10. M.F. Czyzyk-Krzeska, and J. Meller von Hippel-Lindau tumor suppressor: not only HIF's executioner Trends Mol. Med. 10 2004 146 149
11. C. Darby, C.L. Cosma, J.H. Thomas, and C. Manoil Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa Proc. Natl. Acad. Sci. USA 96 1999 15202 15207
12. G. Dechant Chat in the trophic web: NGF activates Ret by inter-RTK signaling Neuron 33 2002 156 158
13. T.L. Deckwerth, and E.M. Johnson Jr. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor J. Cell Biol. 123 1993 1207 1222
14. L. del Peso, M.C. Castellanos, E. Temes, S. Martin-Puig, Y. Cuevas, G. Olmos, and M.O. Landazuri The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen J. Biol. Chem. 278 2003 48690 48695
15. G. De Vita, R.M. Melillo, F. Carlomagno, R. Visconti, M.D. Castellone, A. Bellacosa, M. Billaud, A. Fusco, P.N. Tsichlis, and M. Santoro Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival Cancer Res. 60 2000 3727 3731
16. S.N. Edwards, and A.M. Tolkovsky Characterization of apoptosis in cultured rat sympathetic neurons after nerve growth factor withdrawal J. Cell Biol. 124 1994 537 546
17. A. Epstein, J. Gleadle, L. McNeill, K. Hewitson, J. O'Rourke, D. Mole, M. Mukherji, E. Metzen, M. Wilson, and A. Dhanda C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation Cell 107 2001 43 54
18. S. Estus, W.J. Zaks, R.S. Freeman, M. Gruda, R. Bravo, and E.M. Johnson Jr. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis J. Cell Biol. 127 1994 1717 1727
19. F. Francois, M.J. Godinho, M. Dragunow, and M.L. Grimes A population of PC12 cells that is initiating apoptosis can be rescued by nerve growth factor Mol. Cell. Neurosci. 18 2001 347 362
20. D. Gerald, E. Berra, Y.M. Frapart, D.A. Chan, A.J. Giaccia, D. Mansuy, J. Pouyssegur, M. Yaniv, and F. Mechta-Grigoriou JunD reduces tumor angiogenesis by protecting cells from oxidative stress Cell 118 2004 781 794
21. A.P. Gimenez-Roqueplo, J. Favier, P. Rustin, J.J. Mourad, P.F. Plouin, P. Corvol, A. Rotig, and X. Jeunemaitre The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway Am. J. Hum. Genet. 69 2001 1186 1197
22. L. Greene Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium J. Cell Biol. 78 1978 747 755
23. L.A. Greene, and A.S. Tischler Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc. Natl. Acad. Sci. USA 73 1976 2424 2428
24. V. Gunzler, and K. Weidmann Prolyl 4-hydroxylase inhibitors N.B. Guzman Prolyl Hydroxylase, Protein Disulfide Isomerase, and Other Structurally Related Proteins 1998 Marcel Dekker, Inc. New York 65 95
25. J. Ham, C. Babij, J. Whitfield, C.M. Pfarr, D. Lallemand, M. Yaniv, and L.L. Rubin A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death Neuron 14 1995 927 939
26. Y. Herault, G. Chatelain, G. Brun, and D. Michel V-src-induced- transcription of the avian clusterin gene Nucleic Acids Res. 20 1992 6377 6383
27. M. Hirsila, P. Koivunen, V. Gunzler, K.I. Kivirikko, and J. Myllyharju Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor J. Biol. Chem. 278 2003 30772 30780
28. M. Hoffman, M. Ohh, H. Yang, J. Klco, M. Ivan, and W.J. Kaelin von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF Hum. Mol. Genet. 10 2001 1019 1027
29. E. Holme A kinetic study of thymine 7-hydroxylase from neurospora crassa Biochemistry 14 1975 4999 5003
30. J.S. Isaacs, Y.J. Jung, D.R. Mole, S. Lee, C. Torres-Cabala, Y.-L. Chung, M. Merino, J. Trepel, B. Zbar, and J. Toro HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability this issue Cancer Cell 8 2005 143 153
31. T. Ishii, K. Yasuda, A. Akatsuka, O. Hino, P.S. Hartman, and N. Ishii A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis Cancer Res. 65 2005 203 209
32. M. Ivan, T. Haberberger, D.C. Gervasi, K.S. Michelson, V. Gunzler, K. Kondo, H. Yang, I. Sorokina, R.C. Conaway, J.W. Conaway, and W.G. Kaelin Jr. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor Proc. Natl. Acad. Sci. USA 99 2002 13459 13464
33. G. Jin, and P.H. Howe Regulation of clusterin gene expression by transforming growth factor β J. Biol. Chem. 272 1997 26620 26626
34. W.G. Kaelin Molecular basis of the VHL hereditary cancer syndrome Nat. Rev. Cancer 2 2002 673 682
35. C.D. Katsetos, L. Del Valle, A. Legido, J.P. de Chadarevian, E. Perentes, and S.J. Mork On the neuronal/neuroblastic nature of medulloblastomas: a tribute to Pio del Rio Hortega and Moises Polak Acta Neuropathol. (Berl.) 105 2003 1 13
36. A. Kieser, T. Seitz, H.S. Adler, P. Coffer, E. Kremmer, P. Crespo, J.S. Gutkind, D.W. Henderson, J.F. Mushinski, W. Kolch, and H. Mischak Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells Genes Dev. 10 1996 1455 1466
37. Kim, W.Y., and Kaelin, W.G. (2004). Role of VHL gene mutation in human cancer. J. Clin. Oncol., in press.
38. K. Kondo, J. Klco, E. Nakamura, M. Lechpammer, and W.G. Kaelin Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein Cancer Cell 1 2002 237 246
39. K. Kondo, W.Y. Kim, M. Lechpammer, and W.G. Kaelin Jr. Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth PLoS Biol. 1 2003 e83 10.1371/journal.pbio.0000083
40. G. Lenaz, A. Baracca, V. Carelli, M. D'Aurelio, G. Sgarbi, and G. Solaini Bioenergetics of mitochondrial diseases associated with mtDNA mutations Biochim. Biophys. Acta 1658 2004 89 94
41. E. Lipscomb, P. Sarmiere, R. Crowder, and R. Freeman Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons J. Neurochem. 73 1999 429 432
42. E. Lipscomb, P. Sarmiere, and R. Freeman SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons J. Biol. Chem. 276 2001 11775 11782
43. K.M. Lonergan, O. Iliopoulos, M. Ohh, T. Kamura, R.C. Conaway, J.W. Conaway, and W.G. Kaelin Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau protein requires binding to complexes containing elongins B/C and Cul2 Mol. Cell. Biol. 18 1998 732 741
44. E.R. Maher, and C. Eng The pressure rises: update on the genetics of phaeochromocytoma Hum. Mol. Genet. 11 2002 2347 2354
45. E. Maher, and W.G. Kaelin von Hippel-Lindau disease Medicine 76 1997 381 391
46. J.H. Marxsen, P. Stengel, K. Doege, P. Heikkinen, T. Jokilehto, T. Wagner, W. Jelkmann, P. Jaakkola, and E. Metzen Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4- hydroxylases Biochem. J. 381 2004 761 767
47. P. Maxwell, M. Weisner, G.-W. Chang, S. Clifford, E. Vaux, C. Pugh, E. Maher, and P. Ratcliffe The von Hippel-Lindau gene product is necessary for oxygen-dependent proteolysis of hypoxia-inducible factor α subunits Nature 399 1999 271 275
48. H.R. McLennan, and M. Degli Esposti The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species J. Bioenerg. Biomembr. 32 2000 153 162
49. K. Menzies, B. Liu, W.J. Kim, M.C. Moschella, and M.B. Taubman Regulation of the SM-20 prolyl hydroxylase gene in smooth muscle cells Biochem. Biophys. Res. Commun. 317 2004 801 810
50. C.A. Messam, and R.N. Pittman Asynchrony and commitment to die during apoptosis Exp. Cell Res. 238 1998 389 398
51. E. Metzen, U. Berchner-Pfannschmidt, P. Stengel, J.H. Marxsen, I. Stolze, M. Klinger, W.Q. Huang, C. Wotzlaw, T. Hellwig-Burgel, and W. Jelkmann Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing J. Cell Sci. 116 2003 1319 1326
52. H. Murata, N. Tajima, Y. Nagashima, M. Yao, M. Baba, M. Goto, S. Kawamoto, I. Yamamoto, K. Okuda, and H. Kanno Von Hippel-Lindau tumor suppressor protein transforms human neuroblastoma cells into functional neuron-like cells Cancer Res. 62 2002 7004 7011
53. R. Myllyla, L. Tuderman, and K.I. Kivirikko Mechanism of the prolyl hydroxylase reaction. 2. Kinetic analysis of the reaction sequence Eur. J. Biochem. 80 1977 349 357
54. A. Nakagawara Trk receptor tyrosine kinases: a bridge between cancer and neural development Cancer Lett. 169 2001 107 114
55. H. Neumann, B. Bausch, S. McWhinney, B. Bender, O. Gimm, G. Franke, J. Schipper, J. Klisch, C. Altehoefer, and K. Zerres Germ-line mutations in nonsyndromic pheochromocytoma N. Engl. J. Med. 343 2002 1459 1466
56. M. Ohh, C.W. Park, M. Ivan, M.A. Hoffman, T.-Y. Kim, L.E. Huang, V. Chau, and W.G. Kaelin Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein Nat. Cell Biol. 2 2000 423 427
57. H. Okuda, S. Hirai, Y. Takaki, M. Kamada, M. Baba, N. Sakai, T. Kishida, S. Kaneko, M. Yao, S. Ohno, and T. Shuin Direct interaction of the β-domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes Biochem. Biophys. Res. Commun. 263 1999 491 497
58. H. Okuda, K. Saitoh, S. Hirai, K. Iwai, Y. Takaki, M. Baba, N. Minato, S. Ohno, and T. Shuin The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C J. Biol. Chem. 276 2001 43611 43617
59. S. Pal, K. Claffey, H. Dvorak, and D. Mukhopadhyay The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways J. Biol. Chem. 272 1997 27509 27512
60. M. Palmada, S. Kanwal, N.J. Rutkoski, C. Gustafson-Brown, R.S. Johnson, R. Wisdom, and B.D. Carter c-jun is essential for sympathetic neuronal death induced by NGF withdrawal but not by p75 activation J. Cell Biol. 158 2002 453 461
61. S. Peterson, and E. Bogenmann The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation Oncogene 23 2004 213 225
62. K.H. Schlingensiepen, F. Wollnik, M. Kunst, R. Schlingensiepen, T. Herdegen, and W. Brysch The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo Cell. Mol. Neurobiol. 14 1994 487 505
63. C.J. Schofield, and P.J. Ratcliffe Oxygen sensing by HIF hydroxylases Nat. Rev. Mol. Cell Biol. 5 2004 343 354
64. C.J. Schofield, and Z. Zhang Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes Curr. Opin. Struct. Biol. 9 1999 722 731
65. M.A. Selak, S.M. Armour, E.D. Mackenzie, H. Boulahbel, D.G. Watson, K.D. Mansfield, Y. Pan, M.C. Simon, C.B. Thompson, and E. Gottlieb Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase Cancer Cell 7 2005 77 85
66. M.L. Standaert, M.P. Sajan, A. Miura, Y. Kanoh, H.C. Chen, R.V. Farese Jr., and R.V. Farese Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states J. Biol. Chem. 279 2004 24929 24934
67. J.A. Straub, E.A. Lipscomb, E.S. Yoshida, and R.S. Freeman Induction of SM-20 in PC12 cells leads to increased cytochrome c levels, accumulation of cytochrome c in the cytosol, and caspase-dependent cell death J. Neurochem. 85 2003 318 328
68. M.S. Taylor Characterization and comparative analysis of the EGLN gene family Gene 275 2001 125 132
69. B.A. Tsui-Pierchala, J. Milbrandt, and E.M. Johnson Jr. NGF utilizes c-Ret via a novel GFL-independent, inter-RTK signaling mechanism to maintain the trophic status of mature sympathetic neurons Neuron 33 2002 261 273
70. M.L. Vandenplas, V. Mamidipudi, M. Lamar Seibenhener, and M.W. Wooten Nerve growth factor activates kinases that phosphorylate atypical protein kinase C Cell. Signal. 14 2002 359 363
71. K.S. Vogel, C.I. Brannan, N.A. Jenkins, N.G. Copeland, and L.F. Parada Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons Cell 82 1995 733 742
72. W. Wei, J. Jin, S. Schlisio, J.W. Harper, and W.G. Kaelin Jr. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase Cancer Cell 8 2005 25 33
73. M.W. Wooten, M.L. Vandenplas, M.L. Seibenhener, T. Geetha, and M.T. Diaz-Meco Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway Mol. Cell. Biol. 21 2001 8414 8427
74. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
75. V. Yankovskaya, R. Horsefield, S. Tornroth, C. Luna-Chavez, H. Miyoshi, C. Leger, B. Byrne, G. Cecchini, and S. Iwata Architecture of succinate dehydrogenase and reactive oxygen species generation Science 299 2003 700 704
76. + channel activity in pulmonary artery smooth muscle cells Circulation 104 2001 1557 1563
77. B. Zbar, T. Kishida, F. Chen, L. Schmidt, E.R. Maher, F.M. Richards, P.A. Crossey, A.R. Webster, N.A. Affara, and M.A. Ferguson-Smith Germline mutations in the von Hippel-Lindau (VHL) gene in families from North America, Europe, and Japan Hum. Mutat. 8 1996 348 357
78. M. Zimmer, D. Doucette, N. Siddiqui, and O. Iliopoulos Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors Mol. Cancer Res. 2 2004 89 95